Cargando…
Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review
Familial gastrointestinal stromal tumor (GIST) is a rare autosomal dominant genetic disorder with only a few affected families reported to date. Here, we report a case of familial GISTs harboring a novel germline mutation within exon 18 of KIT. A 58-year-old male patient presented with gastric subep...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820900/ https://www.ncbi.nlm.nih.gov/pubmed/36614290 http://dx.doi.org/10.3390/ijms24010830 |
_version_ | 1784865570715336704 |
---|---|
author | Ge, Qichao Liu, Yang Yang, Fan Sun, Guangwei Guo, Jintao Sun, Siyu |
author_facet | Ge, Qichao Liu, Yang Yang, Fan Sun, Guangwei Guo, Jintao Sun, Siyu |
author_sort | Ge, Qichao |
collection | PubMed |
description | Familial gastrointestinal stromal tumor (GIST) is a rare autosomal dominant genetic disorder with only a few affected families reported to date. Here, we report a case of familial GISTs harboring a novel germline mutation within exon 18 of KIT. A 58-year-old male patient presented with gastric subepithelial lesions accompanied by cutaneous hyperpigmentation, which were subsequently diagnosed as multinodular GISTs. Endoscopic surgery was initially conducted to remove the larger lesions, and pathological examinations were then conducted for the diagnosis of GISTs. Family history revealed that some other family members had similar cutaneous pigmentations. Whole-exome sequencing was used to search for potential driver mutations, and Sanger sequencing was used for mutation validation. A novel primary driver mutation of KIT (c.G2485C, p.A829P) was detected in these hereditary GISTs, which has been reported in some targeted chemotherapy-resistant GISTs. Cell models were subsequently established for the rapid screening of candidate drugs and exploring potential mechanisms. This mutation could lead to cell proliferation and imatinib resistance by ligand-independent activation of KIT; however, ripretinib administration was identified as an applicable targeted therapy for this mutation. The mutation activated the JAK/STAT3 and MAPK/ERK pathways, which could be inhibited by ripretinib administration. To the best of our knowledge, this is the first report of the KIT-A829P mutation in familial GISTs, complementing the pathogenesis of familial GISTs and providing valuable information for the precision treatment of this disease. |
format | Online Article Text |
id | pubmed-9820900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98209002023-01-07 Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review Ge, Qichao Liu, Yang Yang, Fan Sun, Guangwei Guo, Jintao Sun, Siyu Int J Mol Sci Case Report Familial gastrointestinal stromal tumor (GIST) is a rare autosomal dominant genetic disorder with only a few affected families reported to date. Here, we report a case of familial GISTs harboring a novel germline mutation within exon 18 of KIT. A 58-year-old male patient presented with gastric subepithelial lesions accompanied by cutaneous hyperpigmentation, which were subsequently diagnosed as multinodular GISTs. Endoscopic surgery was initially conducted to remove the larger lesions, and pathological examinations were then conducted for the diagnosis of GISTs. Family history revealed that some other family members had similar cutaneous pigmentations. Whole-exome sequencing was used to search for potential driver mutations, and Sanger sequencing was used for mutation validation. A novel primary driver mutation of KIT (c.G2485C, p.A829P) was detected in these hereditary GISTs, which has been reported in some targeted chemotherapy-resistant GISTs. Cell models were subsequently established for the rapid screening of candidate drugs and exploring potential mechanisms. This mutation could lead to cell proliferation and imatinib resistance by ligand-independent activation of KIT; however, ripretinib administration was identified as an applicable targeted therapy for this mutation. The mutation activated the JAK/STAT3 and MAPK/ERK pathways, which could be inhibited by ripretinib administration. To the best of our knowledge, this is the first report of the KIT-A829P mutation in familial GISTs, complementing the pathogenesis of familial GISTs and providing valuable information for the precision treatment of this disease. MDPI 2023-01-03 /pmc/articles/PMC9820900/ /pubmed/36614290 http://dx.doi.org/10.3390/ijms24010830 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Ge, Qichao Liu, Yang Yang, Fan Sun, Guangwei Guo, Jintao Sun, Siyu Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review |
title | Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review |
title_full | Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review |
title_fullStr | Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review |
title_full_unstemmed | Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review |
title_short | Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review |
title_sort | chinese pedigree with hereditary gastrointestinal stromal tumors: a case report and literature review |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820900/ https://www.ncbi.nlm.nih.gov/pubmed/36614290 http://dx.doi.org/10.3390/ijms24010830 |
work_keys_str_mv | AT geqichao chinesepedigreewithhereditarygastrointestinalstromaltumorsacasereportandliteraturereview AT liuyang chinesepedigreewithhereditarygastrointestinalstromaltumorsacasereportandliteraturereview AT yangfan chinesepedigreewithhereditarygastrointestinalstromaltumorsacasereportandliteraturereview AT sunguangwei chinesepedigreewithhereditarygastrointestinalstromaltumorsacasereportandliteraturereview AT guojintao chinesepedigreewithhereditarygastrointestinalstromaltumorsacasereportandliteraturereview AT sunsiyu chinesepedigreewithhereditarygastrointestinalstromaltumorsacasereportandliteraturereview |